Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Return on Assets (2021 - 2023)

Terns Pharmaceuticals' Return on Assets history spans 3 years, with the latest figure at 0.3% for Q3 2023.

  • For Q3 2023, Return on Assets rose 5.0% year-over-year to 0.3%; the TTM value through Sep 2023 reached 0.3%, up 5.0%, while the annual FY2022 figure was 0.27%, 12.0% up from the prior year.
  • Return on Assets reached 0.3% in Q3 2023 per TERN's latest filing, down from 0.24% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.02% in Q2 2021 to a low of 0.36% in Q2 2022.
  • Average Return on Assets over 3 years is 0.22%, with a median of 0.25% recorded in 2022.
  • Peak YoY movement for Return on Assets: plummeted -33bps in 2022, then grew 11bps in 2023.
  • A 3-year view of Return on Assets shows it stood at 0.29% in 2021, then rose by 13bps to 0.25% in 2022, then fell by -20bps to 0.3% in 2023.
  • Per Business Quant, the three most recent readings for TERN's Return on Assets are 0.3% (Q3 2023), 0.24% (Q2 2023), and 0.23% (Q1 2023).